Champions Oncology Q2 FY2025: Revenue $13.5M, Net Income $730K, Adj. EBITDA $1.1M

CHAMPIONS ONCOLOGY, INC.

2025-Q2 EPS reported $0.15 vs consensus -$0.20 ▲ beat (+173.5%)

Q2 revenue rose 17% YoY to $13.5M; gross margin improved to 45% from 43%
Net income of ~$730K vs. $2.0M operating loss a year ago
Adjusted EBITDA of $1.1M, reversed from a $1.4M loss in Q2 FY2024
Company guides FY2025 revenue growth of at least 10%-15%, citing core strength and new data platform revenue
No debt; cash on hand ~$2.8M; data monetization highlighted as a transformative additional revenue stream

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.